A supervising provider assesses compatibility with any concurrent treatments during the initial consultation
Cagrilintide has been characterized in peer-reviewed research and clinical investigation as a potent, selective amylin receptor agonist with an extended pharmacokinetic profile suitable for once-weekly dosing paradigms
Previous work has reported relatively increased Firmicutes and Proteobacteria and decreased Bacteroidetes in mice on an HFD, regardless of concomitant obesity (weight gain was minimized using a RELM knockout mouse 78 ) 78,79
Typically, doctors prescribe a loading dose, which involves multiple injections administered close together, followed by maintenance doses to sustain adequate B12 levels over time
This was followed by a 38-day pharmacokinetic blood sampling and safety assessment period (i.e., 45 times the estimated cagrilintide t 1/2 ), with blood samples collected on days 8, 15, 22, 29 and 39
Related reading What Is Vitamin B12 and Why Does the Body Need It
